RAPAFLO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Silodosin.
| Product ID | 52544-151_01d2cfa3-9fd9-44ef-91db-71e5800d838d |
| NDC | 52544-151 |
| Product Type | Human Prescription Drug |
| Proprietary Name | RAPAFLO |
| Generic Name | Silodosin |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-03-23 |
| Marketing End Date | 2020-10-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022206 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | SILODOSIN |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2009-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022206 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-03-23 |
| Marketing End Date | 2020-10-31 |
| Marketing Category | NDA |
| Application Number | NDA022206 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-03-23 |
| Marketing End Date | 2009-03-23 |
| Marketing Category | NDA |
| Application Number | NDA022206 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-03-23 |
| Marketing End Date | 2020-10-31 |
| Ingredient | Strength |
|---|---|
| SILODOSIN | 4 mg/1 |
| SPL SET ID: | a21163d6-e1b9-4490-bce3-751e0823797c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-6142 | RAPAFLO | silodosin |
| 0023-6147 | RAPAFLO | silodosin |
| 52544-151 | RAPAFLO | silodosin |
| 52544-152 | RAPAFLO | silodosin |
| 0781-2623 | Silodosin | Silodosin |
| 0781-2624 | Silodosin | Silodosin |
| 27241-144 | Silodosin | Silodosin |
| 27241-145 | Silodosin | Silodosin |
| 31722-635 | Silodosin | Silodosin |
| 31722-636 | Silodosin | Silodosin |
| 33342-384 | Silodosin | Silodosin |
| 33342-385 | Silodosin | Silodosin |
| 42291-777 | Silodosin | Silodosin |
| 42291-778 | Silodosin | Silodosin |
| 46708-405 | Silodosin | Silodosin |
| 46708-406 | Silodosin | Silodosin |
| 59651-095 | SILODOSIN | SILODOSIN |
| 59651-096 | SILODOSIN | SILODOSIN |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RAPAFLO 78634385 3644962 Live/Registered |
Watson Pharmaceuticals, Inc. 2005-05-20 |
![]() RAPAFLO 77605175 3681361 Live/Registered |
Watson Pharmaceuticals, Inc. 2008-10-31 |